Recombinant factor VIIa controlled release - Alteogen

Drug Profile

Recombinant factor VIIa controlled release - Alteogen

Alternative Names: FVIIa-NexP

Latest Information Update: 22 Dec 2015

Price : $50

At a glance

  • Originator Alteogen
  • Class Antihaemorrhagics; Blood coagulation factors; Coagulants
  • Mechanism of Action Factor VIIa stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Haemophilia

Most Recent Events

  • 22 Dec 2015 Preclinical trials in Haemophilia in South Korea (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top